KENNEDY CAPITAL MANAGEMENT LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 884589
ST LOUIS, MO
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,332,111
+$1,079,166 QoQ
Shares Held
49,437
-10.2% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#170
of 768 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $47,524,627 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
295,938 | $24,497,747 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,209,068 | $9,575,818 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
49,437 | $8,332,111 | |
| 4 | HROW |
Harrow, Inc.
|
70,748 | $3,004,667 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
48,387 | $837,578 | |
| 6 | VTRS |
Viatris Inc
|
43,906 | $697,227 | |
| 7 | ZTS |
Zoetis Inc.
|
8,064 | $579,479 |
All Filings in NBIX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,332,111 | 49,437 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,252,945 | 55,055 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,673,243 | 47,051 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,899,042 | 56,269 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,721,649 | 53,478 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,376,532 | 57,654 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,929,288 | 36,112 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,574,009 | 31,019 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,920,841 | 28,480 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,583,909 | 33,236 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,817,819 | 21,386 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,801,737 | 51,571 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,343,509 | 56,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,720,192 | 46,633 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,742,342 | 22,960 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,536,825 | 23,885 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $388,555 | 3,986 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||